Express Pharma

JANUARY 26, 2025

The Pharmaceutical Export Promotion Council of India (PHARMEXCIL) announces its renewed commitment to strengthening the strategic partnership between India and the United Arab Emirates (UAE) in the pharmaceutical sector.

Pharmaceutical Manufacturing 82

Pharmaceutical Manufacturing Pharmaceutical Companies Pharmaceutical Companies Vaccines 82

FDA Law Blog: Biosimilars

JANUARY 16, 2025

Hyman, Phelps & McNamara PC, (HPM), which will mark its 45thAnniversary on March 17, 2025, is pleased to announce that it is increasing its directors, counsel, and associates as it starts the year. Richardson has been promoted to Director. Kalie is the quintessential HPM lawyer.

Pharmaceutical Manufacturing 59

Pharmaceutical Manufacturing Drug Development 59

Express Pharma

MARCH 16, 2025

What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceutical manufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands.

Biosimilars 98

Biosimilars Insurance Coverage and Processing Pharmaceutical Companies Pharmaceutical Companies 98

pharmaphorum

NOVEMBER 25, 2022

Located on the outskirts of the historic Italian city – home to Verdi and myriad architectural gems – the press launch and tour of the €85 million Chiesi development was a quintessentially Italian affair, based out of Chiesi’s San Leonardo production site. In-house drug development of biologicals and rare disease targeting.

Drug Development 98

Drug Development Pharmaceutical Manufacturing Diabetes 98

European Pharmaceutical Review

FEBRUARY 20, 2025

4 Reshoring and diversification of pharmaceutical supply chains In response to potential tariffs, pharmaceutical manufacturers could consider shifting production closer to domestic markets to reduce exposure. Trump Tariffs Threaten US Drug Supplies And Risk Higher Prices, Trade Groups Warn. References 1.

Drug Pricing 20

Drug Pricing Pharmaceutical Manufacturing Generic Medicine Hospitals 20

Safe Biologics

MARCH 10, 2025

Small molecule drugs make up over 90% of prescriptions filled in the U.S. Yet, since the IRAs implementation in 2021, investment in small molecule drug development has dropped by 70% as manufacturers shift resources toward biologics, which have more favorable financial incentives under the law. Read the FTC Report here.

Biosimilars 130

Biosimilars Independent Pharmacies Drug Pricing Vaccines 130